Trexquant Investment’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Trexquant Investment’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-389,114	Closed	-$4.43M	–	1915
2024 Q3	$4.43M	Buy	389,114 +111,441	+40%	+$1.12M	0.06%	520
2024 Q2	$1.98M	Buy	277,673 +186,054	+203%	+$1.42M	0.03%	755
2024 Q1	$614K	Sell	91,619 -102,149	-53%	-$703K	0.01%	1085
2023 Q4	$1.26M	Buy	+193,768	New	+$1.25M	0.03%	732
2021 Q3	–	Sell	-23,913	Closed	-$613K	–	1564
2021 Q2	$613K	Buy	23,913 +11,312	+90%	+$242K	0.05%	434
2021 Q1	$230K	Sell	12,601 -8,980	-42%	-$149K	0.02%	908
2020 Q4	$249K	Sell	21,581 -52,646	-71%	-$481K	0.03%	794
2020 Q3	$566K	Buy	+74,227	New	+$562K	0.04%	628

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Trexquant Investment's CDMO Position: Q4 2024 in Review

Trexquant Investment sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 389,114 shares — an estimated $4.43M sold.

Trexquant Investment first reported a position in CDMO in Q3 2020 and held it in 8 quarters. The position peaked at $4.43M in Q3 2024. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

Trexquant Investment reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Trexquant Investment sold 389,114 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $4.43M.
Trexquant Investment first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
Trexquant Investment's Avid Bioservices, Inc. Common Stock position peaked at $4.43M in Q3 2024.
195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Trexquant Investment's 13F filing for Q4 2024, filed 12 Feb 2025.